SCHEMBL7061973

SCHEMBL7061973

Cc1nc(-c2cccc(N(CCC#N)CC(=O)Nc3ccc(-c4ccccc4S(C)(=O)=O)cc3)c2)no1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 5/20 0.39
F2 P00734 4/20 0.39
KMT2A Q03164 2/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 3/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 2/20 0.38
POLB P06746 2/20 0.38
CTSL P07711 1/20 0.37
CTSB P07858 1/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
PRSS1 P07477 3/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
PRSS2 P07478 2/20 0.36
PRSS3 P35030 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
KIFC1 Q9BW19 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7061543 0.84 F2 (0.37) F10F2KMT2ARAB9AMAPT
SCHEMBL7098768 0.77 ALDH1A1 (0.46) F10F2POLBPRSS1PRSS2
SCHEMBL7098774 0.77 PDE4A (0.46) F10F2KMT2ARAB9AMAPT
SCHEMBL7098174 0.76 LMNA (0.42) F10F2KMT2ARAB9AMAPT
SCHEMBL6808404 0.74 HAVCR2 (0.60) KMT2ARAB9AMAPTLMNATP53
SCHEMBL7072269 0.72 F10 (0.42) F10F2MAPTPRSS1PRSS2
SCHEMBL7060807 0.72 PRSS1 (0.57) F10F2PRSS1PRSS2PRSS3
SCHEMBL6298117 0.72 F10 (0.56) F10F2KMT2ARAB9AMAPT
SCHEMBL7068364 0.71 LTB4R2 (0.43) F10KMT2ARAB9AMAPTLMNA
SCHEMBL7061394 0.70 PRSS1 (0.58) F10F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030166694-A1 Glycinamides MERCK PATENT GMBH (DE) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166694-A1 Glycinamides F11, SERPINC1, F13A1 F10 12/4885F2 6/4885KMT2A 2882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.